Trials / Completed
CompletedNCT02625103
The Significance of Deviation in Time From the 12-hour Standard Serum-clozapine Monitoring.
The Significance of Deviation in Time From the 12-hour Standard Serum-clozapine Monitoring
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 48 (actual)
- Sponsor
- Anders Fink-Jensen, MD, DMSci · Academic / Other
- Sex
- All
- Age
- 18 Years – 64 Years
- Healthy volunteers
- Not accepted
Summary
The role of Therapeutic Drug Monitoring (TDM) in clozapine dose adjustment have been debated. Blood samples for s-clozapine monitoring should be drawn 12 hours post dose. The scope of this trial is to describe changes of s-clozapine and s-N-desmethyl-clozapine within the range of 10-14 hours after the last administration of clozapine .
Detailed description
Several factors can influence s-clozapine and thereby the occurence of dose-related adverse reactions and level of treatment response. The role of Therapeutic Drug Monitoring (TDM) in clozapine dose adjustment have been debated. Blood samples for s-clozapine monitoring are recommended to be drawn 12 hours post dose. Uncertainty regarding the timing of blood sampling and the individual pharmakokinetics for clozapine +/- 2 hours from the 12-hour timepoint, leads to uncertainty regarding the comparability of serum concentrations and the information hold within them. The scope of this trial is to describe changes of s-clozapine and s-N-desmethyl-clozapine within the range of 10-14 hours after the last administration of clozapine . In addition we want to investigate if any of the following covariates might affect the change of s-clozapine and s-N-desmethyl-clozapine: Sex, age, BMI, co-medications, signs of infection, caffeine intake and smoking.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Blood sampling | blood samples for s-clozapine and s-desmethyl-clozapine analysis are collected at 10, 11, 12, 13 and 14 hours post evening-clozapine-administration |
| DRUG | Clozapine | Registration of the exact time of drug administration. Also postponement of any morning clozapine administration until ended blood sampling. |
Timeline
- Start date
- 2015-09-01
- Primary completion
- 2015-12-01
- Completion
- 2016-02-01
- First posted
- 2015-12-09
- Last updated
- 2016-02-25
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT02625103. Inclusion in this directory is not an endorsement.